The Asian Scientist 100
Di Li
Institution
National Astronomical Observatories of the Chinese Academy of Sciences
Country
China
Field
Aerospace & Astronomy
Li received the Marcel Grossmann Award for his pioneering contributions in the field of fast radio bursts. Li is the first scientist in China to receive this prize for research conducted within China.
(Photo: The Paper)
AWARDS
- Marcel Grossmann Award
Related articles
South Korea To Resume Whale Hunt, Practice Stopped Since 1986
The Republic of Korea announced last week its plans to hunt whales under a loophole in an international treaty that allows for so-called 'scientific whaling.'
President Hu Jintao: Chinese R&D Needs More Innovation
Top Chinese leaders have called for reforms to China's science and technology program that include innovation and integration with social and economic development.
Shrinking Leaves Linked To Climate Change In Australia
Researchers from Australia and China have discovered that recent climate change is causing leaves of some Australian plants to narrow in size
Does The Chinese Emissions ‘Error’ Matter?
Recent analyses that China's carbon dioxide emissions might be 1.2 gigatons or 20 percent higher than previously estimated have generated something of a feeding frenzy in the media.
MIT Researchers Find High Concentrations Of Lead In Indian Ocean
Researchers from MIT have unearthed high concentrations of lead in the Indian Ocean, as well as areas closer to population centers such as Singapore.
Say That Again? New Telephone Test To Determine Hearing Loss
Researchers have designed a new hearing-screening test in Mandarin for people suffering from hearing loss in China.
AstraZeneca Invests US$200m Into Manufacturing Facility In China Medical City
AstraZeneca today announced a US$200 million investment in a new manufacturing facility, located in China Medical City, Taizhou, Jiangsu province in Eastern China.
NASA Cancels Ambitious Climate Study In Thailand
A complex and ambitious climate study planned by NASA in Southeast Asia has been canceled after Bangkok refused to approve the project.
Eisai Receives Russian Approval For Anti-Epileptic Drug, Zonegran
Eisai Co. Ltd. announced today that it has received Russian regulatory approval for its antiepileptic drug, Zonegran (zonisamide).